Medtronic & NuVasive settle staff contract dispute:
This article was originally published in Clinica
Executive Summary
NuVasive says it has settled long-running litigation with Medtronic Sofamor Danek, a much larger rival in the minimally invasive spinal surgery industry. All lawsuits have been dismissed without prejudice and all future expenses have been removed. The companies agreed to keep the terms of the mediated resolution confidential. Medtronic had alleged San Diego-based NuVasive employed former MSD staff and attempted to obtain confidential information, thereby interfering with MSD employment contracts.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.